At 15, Reyna is a two-year pancreatic cancer survivor. She’s taking steps to end the disease at PanCAN PurpleStride 2026 and wants you to join her!

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit highlights the latest advances in precision medicine ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

Join PanCAN on Thursday, March 26, at 11 a.m. PT / 2 p.m. ET, for our Nutrition Month webinar. Our panel of special guests will talk about common nutritional challenges as well as leading-edge ...